Patent ID: 7655471

Claim:
A method for detecting hyperplasia or adenocarcinoma of the endometrium in a patient, said process comprising measuring the levels of stress-induced phosphoprotein-1 in a sample of a biological fluid acquired from the patient and a sample of the biological fluid acquired from a subject having a normal endometrium, comparing the measured levels, and determining that there is an indication of the presence of hyperplasia or adenocarcinoma of the endometrium in the patient if the level of stress-induced phosphoprotein-1 in the sample of the biological fluid from the patient is higher than the level of stress-induced phosphoprotein-1 in the biological fluid of the subject having a normal endometrium, wherein said stress-induced phosphoprotein-1 comprises the amino acid sequence of SEQ ID NO: 1 (as set forth under GENEMBL database accession number P31948).